Inventor · disambiguated record
I. Robert Silverman
Also filed as: SILVERMAN I ROBERT
14 granted patents·16 pending applications·108 citations·filing 2008–2025
92Inventor score
Files withCONCERT PHARMACEUTICALS INC18SUN PHARMACEUTICAL IND INC4GRAHAM PHILIP B2REVERE PHARMACEUTICALS2VERTEX PHARMACEUTICALS EUROPE LTD2
Top patents by PatentIndex Score
30 records- 0198US9249149B2Deuterated derivatives of ruxolitinibCONCERT PHARMACEUTICALS INC·Filed 2015·Granted Feb 2, 2016·62 cites·15 claims
- 0294US9655895B2Morphinan compoundsCONCERT PHARMACEUTICALS INC·Filed 2016·Granted May 23, 2017·7 cites·20 claims
- 0393US9340512B2Morphinan compoundsCONCERT PHARMACEUTICALS INC·Filed 2015·Granted May 17, 2016·5 cites·15 claims
- 0492US8916582B2Morphinan compoundsCONCERT PHARMACEUTICALS INC·Filed 2014·Granted Dec 23, 2014·7 cites·18 claims
- 0591US10022370B2Morphinan compoundsCONCERT PHARMACEUTICALS INC·Filed 2017·Granted Jul 17, 2018·3 cites·21 claims
- 0689US8710072B2Morphinan compoundsGRAHAM PHILIP B·Filed 2009·Granted Apr 29, 2014·15 cites·15 claims
- 0787US9266837B2Morphinan compoundsCONCERT PHARMACEUTICAL INC·Filed 2014·Granted Feb 23, 2016·5 cites·10 claims
- 0887US2025025467A1Deuterated derivatives of ruxolitinibSUN PHARMACEUTICAL IND INC·Filed 2024·Application pending·0 cites
- 0984US10406155B2Morphinan compoundsCONCERT PHARMACEUTICALS INC·Filed 2018·Granted Sep 10, 2019·2 cites·22 claims
- 1082US2023355629A1Deuterated derivatives of ruxolitinibSUN PHARMACEUTICAL IND INC·Filed 2022·Application pending·0 cites
- 1178US10813926B2Morphinan compoundsCONCERT PHARMACEUTICALS INC·Filed 2019·Granted Oct 27, 2020·0 cites·22 claims
- 1274US2021330674A1Deuterated derivatives of ruxolitinibCONCERT PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1373US10196384B2Deuterated CFTR modulatorsVERTEX PHARMACEUTICALS EUROPE LTD·Filed 2016·Granted Feb 5, 2019·1 cites·29 claims
- 1473US8822498B2Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereofJONES ANDREW D·Filed 2008·Granted Sep 2, 2014·1 cites·4 claims
- 1568US2019308976A1Deuterated derivatives of ruxolitinibCONCERT PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1667US11919907B2Deuterated JAK inhibitor and uses thereofSUN PHARMACEUTICAL IND INC·Filed 2021·Granted Mar 5, 2024·0 cites·24 claims
- 1766US2015197525A1Deuterated derivatives of ruxolitinibCONCERT PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1864US2024425509A1Novel deuterated jak inhibitor and uses thereofSUN PHARMACEUTICAL IND INC·Filed 2024·Application pending·0 cites
- 1964US2010137215A1Novel tetrahydro-1h-pyrido[4,3-b]indolesCONCERT PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2063US10738036B2Deuterated CFTR modulatorsVERTEX PHARMACEUTICALS (EUROPE) LTD·Filed 2018·Granted Aug 11, 2020·0 cites·29 claims
- 2163US2019100484A14-hydroxybutyric acid analogsCONCERT PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2262US2017239254A1Deuterated derivatives of ruxolitinibCONCERT PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2361US2012029007A1Morphinan compoundsGRAHAM PHILIP B·Filed 2011·Application pending·0 cites
- 2460US9315483B2Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereofCONCERT PHARMACEUTICALS INC·Filed 2014·Granted Apr 19, 2016·0 cites·2 claims
- 2553US2025235453A1Triazolopyridazine compounds useful as rac1 inhibitorsREVERE PHARMACEUTICALS·Filed 2022·Application pending·0 cites
- 2652US2025346604A1Triazolopyridazine compounds useful as rac1 inhibitorsREVERE PHARMACEUTICALS·Filed 2025·Application pending·0 cites
- 2752US2015210624A1Deuterated 4-hydroxybutyric acid analogsCONCERT PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2851US2021008018A1Deuterated analogs of d-beta-hydroxybutyric acid and uses thereofCONCERT PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2943US2013338184A12-amino-naphthyridine derivativesCONCERT PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3035US2018016277A1Deuterated tic10CONCERT PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when I. Robert Silverman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →